SunCoast Blood Bank
1760 Mound St
Sarasota FL 34236
Mission

Suncoast Blood Bank provides a reliable supply of quality blood products and services to hospitals and health centers in need.

Leadership
CEO/Executive Director Mr. Scott M. Bush
Board Chair Mrs Kathleen Hargreaves
Board Chair Affiliation Kerkering Barberio
General Info
Organization DBA
DBA
Suncoast Communities Blood Bank
SCBB
Supported Organization
Former Names
Sarasota Community Blood Bank
Suncoast Communities Blood Bank
Tax Exempt Status Public Supported Charity
Incorporation Year 1969
Awarded competitive grant from Community Foundation in the last 5 years? Yes
State Charitable Solicitations Permit Yes May 2015
State Registration Yes May 2014
IRS Letter of Determination
View
Financial Summary
 
 
Projected Revenue $13,739,428.00
Projected Expenses $13,660,758.00
Impact Statement

Accomplishments

  • For SunCoast, patient care and outcomes are its top priority. Although the blood and platelet supply is the safest it has ever been, SunCoast has taken steps to make it even safer by being the first blood bank in the country to acquire the INTERCEPT Blood System for platelets and plasma from the Cerus Corporation. This revolutionary technology significantly reduces the risk of transfusion-transmitted pathogens such as hepatitis B and C, HIV, West Nile virus and bacteria, as well as emerging pathogens such as Chikungunya, malaria, and dengue. Platelets are vital in the treatment of cancer patients, who are also the most vulnerable to fatal complications caused by pathogens. Platelets contaminated with bacteria remain one of the highest causes of transfusion-related mortality, and Pathogen Reduction will become an added layer of protection for transfused platelets and dramatically improve patient outcomes in our community.

    Cerus was part of the team that went to West Africa as part of the Gates Foundation initiative to combat Ebola. Their INTERCEPT Blood System, was used to manufacture convalescent plasma to treat patients. The same technology was used for Ebola patients transferred to the United States for treatment. The technology was just recently approved by the FDA for platelets.

     Cerus created a molecule called amotosalen which is filtered into the platelets and binds itself to DNA and RNA. The unit of platelets is then placed under a UV light which envelopes the pathogens which are then filtered out.

     Emerging "bugs" such as dengue and Chikungunya can be completely removed from platelets via this technology. This is significant because dengue has become prevalent in Florida and Texas. Of the 3,900 lab confirmed cases of Chikungunya, 11 were in the US, and all 11 were in Florida. If these bugs became an epidemic in the region, it would force the cessation of blood collections, mandating that all blood products be imported, at a tremendous expense to the cost of healthcare.

     An added benefit of the technology is that platelets can be released earlier after testing. Because they must be stored at room temperature, platelets are only good for five days. INTERCEPT can increase platelet effective shelf life by as much as half a day. This is significant since less than one percent of the population donates 100 percent of this vital blood product.

  • SunCoast Blood bank has raised $254,065 on a goal of $327,000 to fund a new blood irradiator, the most vital piece of technology necessary to operate the transfusion services of a blood bank. The technology irradiates T-lymphocytes before transfusion, which prevents infections created by graft vs host disease, a nearly always fatal complication. Newborns can only be transfused with irradiated blood, and cancer patients and other patients with compromised immune systems can only be transfused with irradiated blood. SunCoast's current irradiator is 30 years old and some parts are no long manufactured, essentially rendering the current equipment obsolete.

  • The demand to keep the cost of healthcare in check motivates SunCoast to function as lean and efficiently as possible.  As a result, this past year a new position was created to help streamline our blood collections process.  An Operations Analyst position was created to review all aspects of SunCoast Blood Bank’s Recruitment Department standards and procedures as well as provide oversight of its mobile drive planning. This oversight was needed to improve the effectiveness of blood drives and overall program efficiency. The results of these new processes and procedures have drastically improved the overall effectiveness of the Recruitment Department while increasing mobile blood drive efficiency. These changes have manifestly increased both cost savings and revenue of the organization through decreasing the total number of drives without a significant decrease in overall collections. Additionally, the Operations Analyst has helped streamline reporting for the entire organization while providing insightful analytics which allow our executive team to make  impactful business decisions.


  • Upon successful implementation of patient blood management software at Sarasota Memorial Hospital, over the last year, SunCoast has implemented the program at other hospitals it serves with similar success rates.  This program provides highly detailed “vein to vein” data on blood usage. Unnecessary transfusions were reduced 18 percent in 2013, when the system became operational, saving Sarasota Memorial $400,000 and the community 1,400 blood components. Sarasota Memorial Healthcare Foundation provided funding.

Goals

  • Complete the funding necessary to obtain a new blood irradiator.
  • Have INTERCEPT pathogen reduction installed and implemented by summer 2015.
  • Continue implementing patient blood management at the hospitals it serves.
Needs Statement
1. SunCoast is in the very initial phases of reviewing its physical plant and assessing its brick and mortar needs.  As our population ages, the need for blood products is only going to increase. Also with the addition and expansion of programs at Sarasota Memorial hospital, including its likely designation as a Level II trauma center, SunCoast must keep up with the demands to meet  the community needs.  As the FDA mandates the acquisition of new technology, as well as the technology SunCoast obtains voluntarily  to keep the blood supply safe and readily available, it is outgrowing its Mound Street facility. Over the next two years SunCoast will explore the costs associated with either expanding (if possible) at its current location or building in a new location.  The scope of work has not been determined, therefore a cost cannot be estimated at this time.
2. SCBB must raise the funds to purchase the Bio-Array technology. Bio-Array is used to identify, collect and store rare blood types. This is especially beneficial for minorities, as receiving a transfusion from the same ethnic group provides a better patient outcome. Without this technology, SCBB would have to search the country for the needed rare blood type. This technology allows SCBB to collect and store these blood products for up to ten years. The cost to purchase the program with all of the needed components is $62,000.
 
3. Expand the scholarship program to capture young donors who are likely to become life-long donors. Scholarship needs range from $500-$1500
 
4. Maintain and/or acquire collection instruments that enable SCBB to operate as safely and efficiently as possible. Platelet collection kits start at $300. Blood collection machines cost between $40,000-$65,000.
Background Statement
For 66 years, SunCoast Blood Bank (SCBB), has been the sole provider of safe and reliable blood products and services to communities in Southwest Florida. SunCoast also provides transfusion services at several local hospitals. The most common need arises from cancer patients, trauma patients, and surgical patients.  The most vulnerable patients are newborns in crisis needing blood or platelets. SCBB provides a wide range of blood services and medically-ordered therapeutic blood procedures to outpatients and inpatients throughout the region.  SunCoast Blood Bank provides 24/7 care 365 day of the year.
 
SCBB needs an average of 150 units of blood a day to meet the needs of our local hospitals and healthcare facilities. Meeting that requirement is becoming more challenging.  Less than 5% of the United States population donates blood.  Many of our most loyal blood donors, members of the “greatest generation” are no longer able to give. At the same time, the FDA is enforcing tougher safety standards disqualifying a large population of younger potential donors.
 
SunCoast Blood Bank operates five donor centers and conducts over 1,300 mobile blood drives a year. Blood drives are held at schools, businesses, community centers and places of worship seven days a week and account for 60% of all blood collection.
Areas Served
Areas Served
Area
FL- Charlotte
FL- DeSoto
FL- Manatee
FL- Sarasota
Service Categories
Primary Org Type Health Care
Secondary Org Type Health Care
Tertiary Org Type
Keywords
Blood, blood bank, saving lives, cancer treatment, transfusion services
Statement from the Board Chair/Board President

I am proud to help forward the mission of SunCoast Blood Bank, to provide a reliable supply of quality blood products and services to hospitals and health centers in need. We have faced the challenges of today’s economy, and we have thrived.  Thanks to the support of local foundations, businesses, media, civic organizations, individual financial donors, and most of all, our loyal blood donors, SunCoast is stronger than ever. Thanks to the generosity of our community, a new bloodmobile recently hit the streets, allowing SunCoast to host more than 200 additional blood drives.  We have streamlined our operations even further, with new facilities to serve as a staging hub for all of our mobile operations.  When I see Bayflite 2 in the air, I know it can't lift off the ground without the universal donor type O negative blood on board, which is my blood type.  That makes me proud to be a donor and to know that I might be saving someone's life as they are airlifted to a trauma center.  It is a privilege to serve our community and contribute to its well-being.

Kathleen Hargreaves, President
Statement from the CEO/Executive Director

SunCoast Blood Bank (SCBB) was founded in 1949 as the Lower West Coast Blood Bank. Our tagline "Live here. Give here. Stays here.," embodies our purpose. Although the name has changed, our mission to remain a local, independent blood center, providing quality blood products to community hospitals, remains strong. Not only has SCBB prevailed in the unprecedented number of blood bank consolidations in the industry, it has flourished. 

 
SCBB has become a model for independent non-profit blood centers around the country. It was among the first to appoint a Transfusion Safety Officer (TSO) to its staff. The TSO collaborates with clinical and technical personnel to ensure the safe, efficient, and evidence-based use of blood products and blood-related resources. It has also established itself as an industry leader by utilizing patient blood management software (PBM). PBM tracks each individual unit of blood from the time of collection, through testing, matching and actual patient transfusion. This provides comprehensive safety assurance. PBM also allows SCBB and the hospitals it serves to reduce the cost of healthcare while improving patient care.
 
Now I am proud to report that soon we will become the first blood bank in the country to implement the INTERCEPT pathogen reduction technology. Emerging "bugs" such as dengue and Chikungunya can be completely removed from platelets via this technology. This is significant because dengue has become prevalent in Florida and Texas. Of the 3,900 lab confirmed cases of Chikungunya, 11 were in the US, and all 11 were in Florida. If these bugs became an epidemic in the region, it would force the cessation of blood collections, mandating that all blood products be imported, at a tremendous expense to the cost of healthcare.
 
With excellent management, superior technology and dedicated staff, another key to our success is a strong local presence. Unlike other mega blood centers, our structure is totally community based. As a CEO living in the community we serve, with a local board, I am able to move quickly and efficiently to serve the needs of the hospitals and health care providers we work with.

SCBB is grateful for the tremendous support it receives from our community. Our blood donors and our financial donors are the backbone of our organization. We strive each day to be the best, because lives depend on it.
 
Scott Bush, CEO 
Programs
Description

A collaboration with Sarasota Memorial Hospital and Florida Cancer Specialists & Research Institute has enabled SunCoast Blood Bank to participate in groundbreaking cellular therapy (MNC) for patients undergoing ovarian and prostate cancer treatments.

With the ovarian cancer therapy still in the clinical study phase, the prostate cancer program is FDA approved and currently active in many centers across the US.

MNC is an alternative treatment for stage-four prostate cancer patients which utilizes an individual’s own white blood cells to boost his own immune system. The therapy requires the extraction of dendritic cells which are sent to a lab for processing. These are then returned to be re-infused into the patient in the form of a vaccine designed to seek and attack prostate cancer cells. By stimulating the natural ability of immune cells already in the patient’s body, this therapy helps fight advanced prostate cancer.
Budget $180,000
Category Medical Research, General/Other Cancer Research
Program Linked to Organizational Strategy Yes
Population Served Adults Males Adults
Short Term Success

MNC therapy is a rapidly growing and active field as more and more laboratories are finding ways to treat cancer.  Given the time required by each procedure and the regimen of treatments ordered for each patient, it is imperative that patients have access to a local provider of this service. Local patients undergoing prostate cancer treatment that require the MNC procedure no longer have to leave the comfort of their own community to receive care in larger centers.  With the expansion of our services to implement our own therapy center, local patients will have the option to be treated locally by an approved, regulated and suitably prepared institution.

Long Term Success

Only licensed and properly equipped institutions can perform this procedure and SunCoast Blood Bank has the expertise and trained staff to offer this service to our community. MNC therapy is gaining momentum as a plan of treatment as more and more laboratories are finding ways to treat cancer.

Program Success Monitoring

Patients currently undergoing MNC therapy for stage-four prostate cancer are under the supervision of their local oncologist. SCBB works closely with their medical providers during their treatment.

In a clinical trial that supported FDA approval, more men treated with MNC lived longer than men not using same procedure. More men in the same treatment group were alive 3 years after the start of the study than men not treated with the vaccine. The vaccine reduced the risk of death by 22.5% for patients in the treatment group and only 1.5% of men discontinued treatment due to side effects.

Program Success Examples

MNC is an immunotherapy of autologous dendritic cells re-infused into the patient consisting of prostatic acid phosphatase (PAP) linked to granulocyte-macrophage colony-stimulating factor. Sequential phase I and phase II trials were performed to determine the safety and efficacy of the vaccine and to assess its capacity to break. Reports from vaccine manufacturer shows that patients tolerated treatment well. Fever, the most common adverse event, occurred after 15 infusions (14.7%). All patients developed immune responses to the fusion protein used to prepare the vaccine, and 38% developed immune responses to PAP. Three patients had a more than 50% decline in prostate-specific antigen (PSA) level, and another three patients had 25% to 49% decreases in PSA. The time to disease progression correlated with development of an immune response to PAP and with the dose of dendritic cells received immune tolerance to the normal tissue antigen PAP.

Description
The Generation Give Scholarship Program was established in 2006. Studies show that students who begin donating in high school are likely to become life-long donors. The Generation Give program was established to motivate students to donate, thus beginning a life-long service to their community. As the economy began to struggle, the need for financial assistance to obtain the dream of a college education became greater, making SCBB's scholarship program a win-win situation. Students experience first-hand the opportunity to commit a life-saving act, and in turn they are eligible to receive a partial scholarship towards college tuition.
 
To be eligible, a student must donate blood or platelets three times during their senior year or demonstrate support of the SCBB mission by volunteering at least 26 hours their senior year. This can be done by promoting school blood drives, volunteering for SCBB or acting as a "Blood Buddy" during their graduation year. (Blood Buddy is a student volunteer who helps out on the days of the drive). Upon successfully completing these requirements, the student may apply for a scholarship, which if awarded, is paid directly to the college or university.
Budget $20,000
Category Education, General/Other Education, General/Other
Program Linked to Organizational Strategy Yes
Population Served Other Named Groups Other Named Groups Other Named Groups
Short Term Success

Students now account for 25% of total blood donated in our community.  As we face an on-going decrease in the population of adult donors, it is imperative that we continue reaching out to our youth to emphasize the importance of blood donation and the impact they are making in other people's lives by becoming a blood donor.

Long Term Success

National studies show that adolescents who donate blood at least three times are most likely to become life-long blood donors.  Cultivating the next generation of blood donors is one step closer to assure that demand for blood will not exceed supply - an ongoing threat faced by all blood banks.

Program Success Monitoring

Community volunteers and SCBB staff comprise a committee to establish guidelines and to review each scholarship application. As part of the application process, students are asked to evaluate several key areas that helps SCBB determine what best motivates students to become blood donors.

Program Success Examples

SCBB has distributed over $124,000 in college scholarships since the creation of the program. In 2014, 54 high school seniors were awarded more than $24,000 in scholarships. SCBB maintains an extensive database that allows us to track donors. The data indicates that many of our young adult donors, began giving blood in high school.

Description

My Blood, Your Blood (MBYB) program was designed by a team of physicians and educators as a low-prep time, turnkey package to be used either in the classroom or the home-school environment. Through sophisticated animation and microscopy, the program captures the imagination of students of all ages and helps foster an interest in science. The program also emphasizes the value of community service through blood donation and the importance of a healthy lifestyle.

Budget $1,000
Category Education, General/Other
Program Linked to Organizational Strategy Yes
Population Served Children Only (5 - 14 years)
Short Term Success

MBYB contributes to the science curriculum at a time when scores in science are falling. The program contains information useful to students taking the state's FCAT. The support materials given to the student also encourages dialogue with the family about what they have learned about blood and the importance of blood donation.

Long Term Success

Exposing children to the vital nature of blood as part of the body's physiology, plants the seed that blood is a product that is critical to our very survival. The program teaches the science of blood including its role in transporting nutrients, regulating our internal environment and protecting us from disease. The program introduces the importance of blood donation as a life-saving contribution that can begin at the age of 16. This sets the stage for students to participate in blood drives once they are old enough.

Program Success Monitoring

Upon completion of the program, teachers are asked to complete an evaluation. Results of those evaluations indicate that MBYB program is beneficial to the students and that the students enjoy the educational video, materials and pencils.  Teachers also find that this program is relevant with the class’s current curriculum.  The program is consistently rated as well-organized, well-presented, age appropriate, and “kid friendly”. 

Suggestions for improvement are predominately for more hands-on activities (hands-on activities are available for presenters to use). A pilot high school home school program was initiated for the 2011-2012 school year with a team approach of the program presenter and a SCBB registered nurse. All the students elected to have their blood typed.
Program Success Examples

Comments from surveys regarding plans for follow up included a microscope activity, using blood cell slides, quizzes and activities provided in the packets.  Requests that the program be executed again appeared on many surveys.  Follow up with the 2011-2012 on-going pilot for high school home schooled students: Students are recruiting donors as part of their community service hours, those who are old enough donate, and the science teacher incorporates more information about blood and the circulatory system before each blood drive. 

Description

SunCoast has taken steps to make the blood supply even safer by being the first blood bank in the country to acquire the INTERCEPT Blood System for platelets and plasma. This revolutionary technology significantly reduces the risk of transfusion-transmitted pathogens such as hepatitis B and C, HIV, West Nile virus and bacteria, as well as emerging pathogens such as Chikungunya, malaria, and dengue. Platelets are vital in the treatment of cancer patients, who are also the most vulnerable to fatal complications caused by pathogens. Platelets contaminated with bacteria remain one of the highest causes of transfusion-related mortality, and Pathogen Reduction will  dramatically improve patient outcomes in our community.

Cerus created a molecule called amotosalen which is filtered into the platelets and binds itself to DNA and RNA. The unit of platelets is then placed under a UV light which envelopes the pathogens which are then filtered out.

Budget $50,000
Category Health Care, General/Other Blood Banking
Program Linked to Organizational Strategy Yes
Population Served Adults Children and Youth (0 - 19 years) Aging, Elderly, Senior Citizens
Short Term Success
Because platelets contaminated with bacteria remain one of the highest causes of transfusion-related mortality, and Pathogen Reduction will dramatically reduce this possibility and improve patient outcomes in our community. An added benefit of the technology is that platelets can be released earlier after testing. Because they must be stored at room temperature, platelets are only good for five days. INTERCEPT can increase platelet effective shelf life by as much as half a day. This is significant since less than one percent of the population donates 100 percent of this vital blood product.
 
Emerging "bugs" such as dengue and Chikungunya can be completely removed from platelets via this technology. This is significant because dengue has become prevalent in Florida and Texas. Of the 3,900 lab confirmed cases of Chikungunya, 11 were in the US, and all 11 were in Florida. If these bugs became an epidemic in the region, it would force the cessation of blood collections.
Long Term Success Currently the technology is only approved for platelets.  The blood banking industry is hopeful that the FDA will approve the technology for red cells.  This would enhance the safety of the blood supply on an entirely new level.
Program Success Monitoring The community should see a significant reduction in the number of bacteria-related complications.
Program Success Examples

The most relevant example is the use of the technology to combat the Ebola epidemic. Cerus was part of the team that went to West Africa as part of the Gates Foundation initiative to combat Ebola. Their INTERCEPT Blood System, was used to manufacture convalescent plasma to treat patients. The same technology was used for Ebola patients transferred to the United States for treatment.

Comments
Program Comments by Organization
The biggest challenge is containing the cost of collecting, testing, storing and transfusing blood products.  Hospitals are under pressure to keep the cost of healthcare in line and this filters down to the blood bank.  SunCoast has one of the leanest operations in the country due to its efficient operations and skilled staff. Most of the blood bankassociated technology is mandated by the FDA and is constantly evolving, improving and emerging.  SunCoast must rely on voluntary financial contributions to cover the cost of the technology required to keep the blood supply safe and available.
 
Another challenge continues to be the shrinking donor pool.  In order to attract and retain donors, SCBB recently launched an online donor rewards program, where donors can redeem points awarded from donating blood or platelets. Points can be redeemed for gift cards and SCBB merchandise. SCBB has also increased its visibility by partnering with local media outlets, including ABC 7, WUSF, WCTQ, WSRZ. 92.1 The Coast, The Bradenton Herald and Sarasota Herald Tribune. 
 
Scott Bush, CEO 
Program Comments by Foundation
CEO/Executive Director
CEO/Executive Director Mr. Scott M. Bush
CEO Term Start Aug 2011
CEO/Executive Director Email sbush@scbb.org
Experience

Scott has over 20 years of experience in blood banking and joined SCBB in 2005 as Director of Donor Services and Recruitment. Most recently, Bush served as Chief Operating Officer, overseeing SCBB’s expansion into Manatee and Charlotte counties.  During his employment at SCBB, Bush was recognized as a Top 40 Under 40 by the Gulf Coast Business Review in 2009 and also was awarded Executive of the Year by the Florida Association of Blood Banks in 2008. Prior to joining SCBB, Bush worked with the American Red Cross for 15 years overseeing various departments within their biomedical service operation.  Bush also served in the United States Naval Reserve where he received the Navy Medal of Achievement.
Scott is a graduate of Ohio Dominican University and earned his masters degree in non-profit management from University of Central Florida. He resides in Parrish.

Former CEOs/Executive Directors
NameTerm
Mr. Kevin Lindberg Dec 2010 - Aug 2011
Dr. Mark J. Magenheim May 2003 - Dec 2010
Senior Staff
NameTitle
Mr. Jason Carney Chief Operating Officer and Transfusion Safety Officer
Mr. Christopher Ebert Information Technology Director
Mrs. Chris Flood Director of Laboratory Services
Mrs. Ginger Fudge Director of Recruitment
Mrs. Jayne Giroux Director of Community Development
Mr. Robert Harper Director of Quality Assurance
Mrs. Karen Hoder Accounting Supervisor
Ms. Laura Williams Dircetor of Human Resources
Staff & Volunteer Statistics
Full Time Staff 91
Part Time Staff 38
Staff Retention Rate % 85.4
Professional Development Yes
Contractors 0
Volunteers 75
Management Reports to Board Yes
CEO/Executive Director Formal Evaluation Yes
Senior Management Formal Evaluation Yes
Non-Management Formal Evaluation Yes
Collaborations
  • Alliance for Community Transfusion Services
  • Blood Centers of America
  • Florida Cancer Specialists & Research Institute
  • Sarasota Memorial Hospital
  • American Heart Association
  • Animal Rescue Coalition
  • Manatee Memorial Hospital Foundation
  • Wildlife Rescue
Affiliations
AffiliationYear
2000
2000
2000
External Assessments and Accreditations
Assessment/AccreditationYear
State of Florida Clinical Laboratory License2013
AABB Transfusion Activities Accreditation2015
Awards & Recognition
Award/RecognitionOrganizationYear
Dorothy M. Hansen Admnistrator of the YearFlorida Association of Blood Banks2011
Most Creative Donor Center EventFlorida Association of Blood Banks2013
Terumo BCT Award of Excellence in Donor RecruitmentAmerica's Blood Centers2013
The Most Creative Donor Center AwardFlorida Association of Blood Banks2012
Board Memeber of the Year - Maggie VeenemanFlorida Association of Blood Banks2012
Media of the Year Award - WSRZ 107.9America's Blood Centers2012
High School Achievement Award for a Mid-Size School - Sarasota Military AcademyFlorida Association of Blood Banks2012
Overall Most Productive Blood Drive - WSRZ 107.9Florida Association of Blood Banks2013
Media Partnership of the Year- WWSB ABC 7Florida Association of Blood Banks2013
Dorothy C Smith R.N. Award - John HorneFlorida Association of Blood Banks2014
Hospital Donor Group Achievement Award - Fawcett Memorial HospitalFlorida Association of Blood Banks2014
Hospital Partnership Award - Sarasota Memorial HospitalFlorida Association of Blood Banks2014
Donor Chairperson of the Year - Leslie CollierFlorida Association of Blood Banks2014
High School Achievement Award for Highest Participation of Mid-Sized Schools - Desoto High SchoolFlorida Association of Blood Banks2014
Terumo BCT Award of Excellence in Donor RecruitmentAmerica's Blood Centers2015
ITxM Award for Excellence in Technical OperationsAmerica's Blood Centers2015
Outstanding Humanitarian Service AwardAmerica's Blood Centers2015
Board Member of the Year - Mary Ann LeglerFlorida Association of Blood Banks2015
Most Creative Donor Center AwardFlorida Association of Blood Banks2015
Media Partnership Service AwardFlorida Association of Blood Banks2015
Innovation AwardFlorida Association of Blood Banks2015
Hopsital Medical Professional Advocate of the Year AwardFlorida Association of Blood Banks2015
Dorothy M. Hansen Executive of the Year Award - Jason CarneyFlorida Association of Blood Banks2015
High School Achievement Award for Highest Participation of Large-Sized Schools - Manatee High SchoolFlorida Association of Blood Banks2015
High School Achievement Award for Most Donations of Large-Sized Schools - Manatee High School2015
Finalist - Champions of Healthcare AwardsManatee Chamber of Commerce2015
Finalist - Healtcare/Wellness Organization of the Year Small Business AwardsSarasota Chamber of Commerce2015
Risk Management Provisions
Automobile Insurance and Umbrella or Excess Insurance
Accident and Injury Coverage
Builders Risk
Commercial General Liability
Computer Equipment and Software
Disability Insurance
Employee Dishonesty
Fiduciary Liability
Flood
General Property Coverage
Life Insurance
Medical Health Insurance
Professional Liability
Workers Compensation and Employers' Liability
Government Licenses
Organization Licensed by the Government Yes
Plans
Fundraising Plan Yes
Communication Plan No
Strategic Plan No
Strategic Plan Years 2
Strategic Plan Adopted Sept 2013
Management Succession Plan No
Policies and Procedures Yes
Continuity of Operations Plan No
Policies
Nondiscrimination Policy Yes
Whistle Blower Policy Yes
Document Destruction Policy Yes
Directors and Officers Insurance Policy Yes
Comments
Management Comments by Organization
SCBB is fortunate to have a staff of dedicated employees committed to our mission.  The senior staff each oversee a pivotal portion of our operation and are experts in their fields.
 
Scott Bush, CEO 
Management Comments by Foundation
Board Chair
Board Chair Mrs Kathleen Hargreaves
Company Affiliation Kerkering Barberio
Board Term Nov 2014 to Oct 2016
Board Chair Email khargreaves@kbgrp.com
Board Members
Board Members
NameAffiliation
Mr. Charles H. Ball Charles H. Ball and Associates P.A.
Mr. Marty Black Thomas Ranch Land Partners
Steve Branham Retired
Mr. William Dooley Dooley Mack
Mr. James Gabbert Gabbert Investment Group
Mr. Chris Gray Community Volunteer
Mrs. Kathleen Hargreaves Kerkering Barberio
Mr. Ben Hatcher Capstan Financial Group
Mrs. Mary Ann Legler Manatee County School Board
Mr. Kelvin Lumpkin Community Volunteer
Mr. Alan Maio Kimley-Horn & Associates
Mr. Jeff Reynolds Retired
Mr. Craig Tuley SunTrust
Mrs. Margaret Veeneman Sarasota Financial Partners
Student serving on the board through Community Youth Development? No
Board Demographics - Ethnicity
African American/Black 1
Asian American/Pacific Islander 0
Caucasian 13
Hispanic/Latino 0
Native American/American Indian 0
Other 0 0
Board Demographics - Gender
Male 11
Female 3
Unspecified 0
Governance
Board Term Lengths 3
Board Term Limits 3
Board Orientation Yes
Number of Full Board Meetings Annually 8
Board Meeting Attendance % 75
Board Self-Evaluation No
Written Board Selection Criteria No
Written Conflict of Interest Policy Yes
% of Board Making Monetary Contributions 100
% of Board Making In-Kind Contributions 20
Constituency Includes Client Representation No
Standing Committees
Audit
Board Development / Board Orientation
Board Governance
Finance
Human Resources / Personnel
Strategic Planning / Strategic Direction
Comments
Governance Comments by Organization
Unlike large blood bank conglomerates, the SCBB Board of Directors plays a pivotal role in the direction of the organization.  Blood banking is a highly regulated, technical institution and it takes more time than is traditional for board members to feel comfortable in their decision making role.  They must understand the technology and the operational needs in order to make informed decisions about capital items as well as policies.  For this reason, term limits are longer than you might see with other nonprofits. 
 
Greater emphasis is being placed on fund development and the role of the board. Therefore, SCBB is seeking potential board members with the willingness and aptitude to immerse themselves in this process. 
 
Scott Bush, CEO 
Governance Comments by Foundation
Fiscal Year Projections
Fiscal Year Begins 2014
Fiscal Year Ends 2015
Projected Revenue $13,739,428.00
Projected Expenses $13,660,758.00
Endowment Value
Endowment Spending Policy Income plus capital appreciation
Endowment Spending Policy %
Capital Campaign
In a Capital Campaign Yes
Campaign Purpose Purchase a Rad Source 4pi X-Ray Blood Irradiator. This instrument is vital to our mission to provide safe and reliable blood products as it eradicates antigens from blood which can cause a life-threatening reaction in transfusion patients.
Campaign Goal $327,800.00
Campaign Dates Oct 2014 to Sept 2015
Amount Raised To Date 204065 as of Feb 2015
Capital Campaign Anticipated in Next 5 Years? Yes
Historical Financial Review
Revenue SourcesHelpThe financial analysis involves a comparison of the IRS Form 990 and the audit report (when available) and revenue sources may not sum to total based on reconciliation differences. Revenue from foundations and corporations may include individual contributions when not itemized separately.
Fiscal Year201420132012
Foundation and
Corporation Contributions
$0$0$0
Government Contributions$0$0$0
Federal$0$0$0
State$0$0$0
Local$0$0$0
Unspecified$0$0$0
Individual Contributions$37,082$251,632$321,887
$0$0$0
$12,841,019$13,077,248$12,979,715
Investment Income, Net of Losses$80,147$62,178$57,104
Membership Dues$0$0$0
Special Events$26,551$64,369$58,619
Revenue In-Kind$271,468$232,920$207,469
Other$25,451$32,142$25,309
Expense Allocation
Fiscal Year201420132012
Program Expense$12,594,549$12,354,077$12,277,342
Administration Expense$888,320$973,969$843,447
Fundraising Expense$75,437$111,242$99,923
Payments to Affiliates$0$0$0
Total Revenue/Total Expenses0.981.001.02
Program Expense/Total Expenses93%92%93%
Fundraising Expense/Contributed Revenue119%35%26%
Assets and Liabilities
Fiscal Year201420132012
Total Assets$9,210,723$9,565,096$9,124,937
Current Assets$5,200,979$6,497,405$6,017,801
Long-Term Liabilities$179,000$108,000$0
Current Liabilities$1,125,358$1,308,032$1,118,795
Total Net Assets$7,906,365$8,149,064$8,006,142
Top Funding Sources
Fiscal Year201420132012
Top Funding Source & Dollar AmountProcessing and service fees $8,991,935Process & Service Fees $10,187,255Process & Service Fees $10,146,721
Second Highest Funding Source & Dollar AmountLab Test Fees $1,978,295Lab Test Fees $2,011,229Laboratory Test Fees $2,147,413
Third Highest Funding Source & Dollar AmountExport Fees $1,162,404Plasma Sales $627,670Plasma Sales $581,531
CEO/Executive Director Compensation $125,001 - $150,000
Co-CEO/Executive Director Compensation
Tax Credits No
Solvency
Short Term Solvency
Fiscal Year201420132012
Current Ratio: Current Assets/Current Liabilities4.624.975.38
Long Term Solvency
Fiscal Year201420132012
Long-Term Liabilities/Total Assets2%1%0%
Financials Comments
Financial Comments by Organization

Blood centers are unique among not-for-profit organizations in that when operating efficiently, our operating expenses can be covered from fees charged for our products and services.  I am proud to report that SunCoast Blood Bank’s operation is extremely efficient and cost effective. In the rare event of a natural or other disaster if hospital demand were to exceed SunCoast’s current level of supply, we also maintain funds which would enable us to purchase and import blood products from other parts of country.  Our primary challenge is absorbing the costs of capital equipment.  These purchases are not luxuries.  Rather, they are necessities often mandated by the Federal Drug Administration in order for us to continue to safely collect, manufacture, store, and deliver blood components.  We allocate a significant amount of funds toward capital improvements, however, the mandated and medically advised advancements required often exceed our ability to pay.  Therefore, we rely on the generosity of foundations and individuals to help us remain operational as we strive to maintain a safe and reliable blood supply for our community. 

Scott Bush, CEO 

Financial Comments by Foundation
Financial figures taken from IRS Form 990 and audit documents.  990s and audits are reconciled for 2009 and 2010.  Total liabilities reported in 2008 audit: $776,879.  Individual contributions include foundation and corporate support, as reported on Form 990. In-kind contribution revenue includes non-cash contributions and donated services and use of facilities as reported on the IRS Form 990.  Donated services and facilities are not included in total revenue on the IRS Form 990.  For 2014, financial information has been taken from the audited financial statements as the Federal 990 has not yet been provided.
 
Nonprofit SunCoast Blood Bank
Address 1760 Mound St
Sarasota, FL 34236
Primary Phone 941 954-1600 124

THE COMMUNITY FOUNDATION OF SARASOTA COUNTY, INC. IS A REGISTERED 501(C)(3) NON-PROFIT CORPORATION. A COPY OF THE OFFICIAL REGISTRATION AND FINANCIAL INFORMATION MAY BE OBTAINED FROM THE DIVISION OF CONSUMER SERVICES BY CALLING TOLL-FREE WITHIN THE STATE (1-800-HELP-FLA) OR FROM THE WEBSITE: WWW.FRESHFROMFLORIDA.COM. REGISTRATION DOES NOT IMPLY ENDORSEMENT, APPROVAL, OR RECOMMENDATION BY THE STATE. ONE HUNDRED PERCENT (100%) OF EACH CONTRIBUTION IS RECEIVED BY THE COMMUNITY FOUNDATION OF SARASOTA COUNTY. REGISTRATION #SC-02471.